Spectroscopy Since 1975

Peptide LC-MS workflow

22 March 2021 | Product
by Ian Michael

Waters has introduced a new peptide multi-attribute method (MAM) workflow for their BioAccord™ LC-MS system, enabling the monitoring of the efficacy and safety of monoclonal antibodies (mAbs) and other protein-based drugs. The peptide MAM workflow for the BioAccord System monitors for product variants, product degradation and impurities, and process stability-indicating modifications. The BioAccord System consists of the ACQUITY™ UPLC™ I-Class Plus with the ACQUITY RDa™ mass detector. In addition to peptide MAM, the BioAccord System also features workflows for other routine analyses of biotherapeutics: peptide mapping, intact/subunit mass analysis, released glycan profiling and oligonucleotide mass confirmation.

Request Information about this Product

By submitting this form you agree that we may pass this information to the company who you are enquiring about.

Request Quote for this Product

By submitting this form you agree that we may pass this information to the company you are requesting the quote from.